Mónica
Álvarez Cordoba
Researcher in the period 2015-2022
Publications (35) Mónica Álvarez Cordoba publications
2023
-
Actin Polymerization Defects Induce Mitochondrial Dysfunction in Cellular Models of Nemaline Myopathies
Antioxidants, Vol. 12, Núm. 12
-
Alpha-lipoic acid supplementation corrects pathological alterations in cellular models of pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
Orphanet journal of rare diseases, Vol. 18, Núm. 1, pp. 80
-
Antioxidants Prevent Iron Accumulation and Lipid Peroxidation, but Do Not Correct Autophagy Dysfunction or Mitochondrial Bioenergetics in Cellular Models of BPAN
International Journal of Molecular Sciences, Vol. 24, Núm. 19
-
Mitochondrial Quality Control via Mitochondrial Unfolded Protein Response (mtUPR) in Ageing and Neurodegenerative Diseases
Biomolecules, Vol. 13, Núm. 12
-
Neurodegeneration, Mitochondria, and Antibiotics
Metabolites, Vol. 13, Núm. 3
-
Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration
Pharmaceuticals, Vol. 16, Núm. 10
-
Vicious cycle of lipid peroxidation and iron accumulation in neurodegeneration
Neural Regeneration Research, Vol. 18, Núm. 6, pp. 1196-1202
-
mtUPR Modulation as a Therapeutic Target for Primary and Secondary Mitochondrial Diseases
International Journal of Molecular Sciences, Vol. 24, Núm. 2
2022
-
Activation of the Mitochondrial Unfolded Protein Response: A New Therapeutic Target?
Biomedicines, Vol. 10, Núm. 7
-
Modeling Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome Using Patient-Derived Induced Neurons Generated by Direct Reprogramming
Cellular reprogramming, Vol. 24, Núm. 5, pp. 294-303
-
Pantothenate and L-Carnitine Supplementation Improves Pathological Alterations in Cellular Models of KAT6A Syndrome
Genes, Vol. 13, Núm. 12
-
Pterostilbene in Combination With Mitochondrial Cofactors Improve Mitochondrial Function in Cellular Models of Mitochondrial Diseases
Frontiers in Pharmacology, Vol. 13
-
Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
Orphanet journal of rare diseases, Vol. 17, Núm. 1, pp. 311
-
UPRmt activation improves pathological alterations in cellular models of mitochondrial diseases
Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1
-
Vitamin E prevents lipid peroxidation and iron accumulation in PLA2G6-Associated Neurodegeneration
Neurobiology of Disease, Vol. 165
2021
-
Coenzyme q10 analogues: Benefits and challenges for therapeutics
Antioxidants, Vol. 10, Núm. 2, pp. 1-20
-
Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives
Orphanet Journal of Rare Diseases, Vol. 16, Núm. 1
-
From mitochondria to atherosclerosis: The inflammation path
Biomedicines, Vol. 9, Núm. 3, pp. 1-24
-
Mitochondria and antibiotics: For good or for evil?
Biomolecules, Vol. 11, Núm. 7
2020
-
Advances in mt-tRNA Mutation-Caused Mitochondrial Disease Modeling: Patients’ Brain in a Dish
Frontiers in Genetics, Vol. 11